PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Leading computational scientist & oncology researcher Elana Fertig appointed new Director of the Institute for Genome Sciences

Internationally-recognized for her work in developing predictive models for drug resistance in cancer treatment

Leading computational scientist & oncology researcher Elana Fertig appointed new Director of the Institute for Genome Sciences
2024-08-28
(Press-News.org) University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Elana J. Fertig, PhD, FAIMBE, as the new Director of the School’s Institute for Genome Sciences (IGS). She is  internationally-recognized for her work in integrating spatial multi-omics technologies with mathematical models to develop a new predictive medicine paradigm in cancer. Spatial technologies allow researchers to learn about any cell type inside of natural tissue, including gene activity and cell interactions.

Dr. Fertig is currently a Professor of Oncology at the Johns Hopkins University with dual appointments in the Department of Applied Mathematics and Statistics and the Department of Biomedical Engineering. She also serves as the Co-Director of the Single Cell Consortium at the Johns Hopkins University School of Medicine, as well as the Co-Director of the Convergence Institute and the Associate Director of Quantitative Sciences at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Her landmark research involves using computational methods to identify biomarkers and molecular mechanisms of therapeutic resistance from a vast trove of multi-platform genomics data.

IGS was founded in 2007 by Claire Fraser, PhD, who was president and director of The Institute for Genomic Research (TIGR) in Rockville, MD and who brought with her some of the faculty from there. Dr. Fraser was instrumental in creating high-throughput sequencing which changed the field of gene discovery and was part of the team to first map the complete genetic code of a free-living organism, Haemophilus influenza. In 2023, Dr. Fraser was elected to the National Academy of Sciences based on her ground-breaking scientific accomplishments during her career in genomic and microbial sciences.

Dr. Fraser served on the search committee for the new IGS director: “With her leadership experience building a quantitative and technological oncology program at Hopkins," Dr. Fraser said. "I have no doubt that Dr. Fertig is perfectly positioned to lead IGS into the future and to new heights.”

Added Dean Gladwin: “Building on the legacy of founder Claire Fraser, PhD, the IGS is poised for even greater success by using genomic research mathematical models to enable researchers to understand the intricate interaction between genes, proteins, and environmental factors.” He is also the John Z. and Akiko K. Bowers Distinguished Professor and Dean, UMSOM, and Vice President for Medical Affairs, University of Maryland, Baltimore. “Dr. Fertig’s expertise, in using computational methods to blend mathematical modeling and artificial intelligence, will be an invaluable asset to IGS as faculty continue to revolutionize genomic science and apply technologies to basic science and clinical research.”

IGS research spans from basic evolutionary science to human health across the lifespan, with scientists applying genomics, microbiome, and systems biology approaches to better understand health issues, evolutionary biology, and the underpinnings of aging, cancer, brain development, addiction, and mental health. Current research projects include using metagenomics (the DNA makeup of multiple species of bacteria) to learn more about the function of the microbiome in the human body and the development of brain databases that include genetic data to investigate brain regions involved in persistent HIV infections, substance use disorder, and psychiatric and neurodevelopmental disorders.

During her 16 years at Hopkins, Dr. Fertig has built a transdisciplinary lab, with researchers spanning diverse scientific backgrounds to bridge the fields of mathematical theory, software development, cancer biology, and clinical oncology, all vital to help achieve her mission: to account for the complex evolutionary processes in cancer for therapeutic selection. With over 130 research publications, she is currently principal investigator or core lead on several National Cancer Institute Consortia grants, including the Cancer Systems Biology, Informatics Technologies for Cancer Research, and Translational and Basic Science in Early Lesions Consortia, and the National Institute of Aging Mouse SenNet Consortium. She is a co-investigator on several other major grants totaling more than $30 million.

“It’s humbling to have the opportunity to take on the Directorship of IGS and continue its rich legacy tracing its roots back to TIGR and the earliest advances in modern genomics research, while personally returning to the University of Maryland System,” said Dr. Fertig. “As Director, I look forward to continuing to foster IGS’s application and development of genomics technologies throughout human health, and to building new bridges to further cancer genomics and computational biology through partnerships with the Greenbaum Comprehensive Cancer Center and the Institute for Health Computing.”

The search committee was headed by Taofeek Owonikoko, MD, PhD,  the Marlene and Stewart Greenebaum Professor of Oncology at UMSOM and Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).

“In Dr. Fertig, we found the ideal visionary who will work to align IGS with the clinical and research missions of the Greenebaum Cancer Center as well with other UMSOM clinical departments to deliver cutting-edge advances in genome research and clinical genomic testing,” said Dr. Owonikoko. “Her experience in developing novel computational methods to analyze multidimensional data from advanced sequencing technology platforms will help advance our precision medicine mission that will ultimately improve treatments and outcomes for patients.”

Dr. Fertig earned a B.S. in Physics and Mathematics at Brandeis University and received her Ph.D. in Applied Mathematics from the University of Maryland, College Park (UMCP). Her unique blend interpreting biological systems by integrating these high-throughput data with artificial intelligence and mathematical modeling techniques is informed by her background in applied mathematics and numerical weather prediction from her graduate training at UMCP. She was a postdoctoral fellow in the Department of Oncology at Johns Hopkins University before accepting a faculty position at the university.

“I want to thank our entire search committee, led by Dr. Taofeek Owonikoko who made this recruitment come to fruition,” said Dean Gladwin. “I also want to extend my deep appreciation to Dr. Jacques Ravel for his leadership, dedication, and commitment to IGS in serving as Acting Director for more than two years.” 

END

[Attachments] See images for this press release:
Leading computational scientist & oncology researcher Elana Fertig appointed new Director of the Institute for Genome Sciences Leading computational scientist & oncology researcher Elana Fertig appointed new Director of the Institute for Genome Sciences 2

ELSE PRESS RELEASES FROM THIS DATE:

UVA research cracks the autism code, making the neurodivergent brain visible

UVA research cracks the autism code, making the neurodivergent brain visible
2024-08-28
A multi-university research team co-led by University of Virginia engineering professor Gustavo K. Rohde has developed a system that can spot genetic markers of autism in brain images with 89 to 95% accuracy. Their findings suggest doctors may one day see, classify and treat autism and related neurological conditions with this method, without having to rely on, or wait for, behavioral cues. And that means this truly personalized medicine could result in earlier interventions. “Autism is traditionally diagnosed behaviorally but has a strong genetic basis. A genetics-first approach could ...

Marine engineering group to award ORNL researchers for innovative welding software

Marine engineering group to award ORNL researchers for innovative welding software
2024-08-28
Zhili Feng, a distinguished R&D staff member, and Jian Chen, a senior R&D staff member, in Materials Science and Technology Division at the Department of Energy’s Oak Ridge National Laboratory, will receive the Elmer L. Hann Award at the Society of Naval Architects and Maritime Engineers, or SNAME, Convention on Oct. 15 in Norfolk, Virginia. SNAME plays a crucial role in promoting excellence in marine engineering and naval architecture, supporting professionals through education, research and collaboration. The award is presented to authors of the best paper on ship production delivered at a SNAME event. In September 2023, Feng and Chen presented “Develop ...

UBC engineers develop all-in-one solution to catch and destroy ‘forever chemicals’

UBC engineers develop all-in-one solution to catch and destroy ‘forever chemicals’
2024-08-28
Chemical engineers at the University of British Columbia have developed a new treatment that traps and treats PFAS substances—widely known as “forever chemicals”—in a single, integrated system. Per- and polyfluoroalkyl substances (PFAS) are widely used in manufacturing consumer goods like waterproof clothing due to their resistance to heat, water and stains. However, they are also pollutants, often ending up in surface and groundwater worldwide, where they have been linked to cancer, liver damage and ...

Purdue researchers take inspiration from viruses to improve delivery of nucleic acid-based therapies to cancer cells

Purdue researchers take inspiration from viruses to improve delivery of nucleic acid-based therapies to cancer cells
2024-08-28
WEST LAFAYETTE, Ind. — A researcher in Purdue University’s College of Science is developing a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells. David Thompson leads a team developing the carrier system called LENN. He is a professor in the James Tarpo Jr. and Margaret Tarpo Department of Chemistry and on the faculty of the Purdue Institute for Cancer Research and the Purdue ...

New USC research reveals untapped potential for mobilizing voters of color in battleground states

New USC research reveals untapped potential for mobilizing voters of color in battleground states
2024-08-28
With swing states playing a pivotal role in the 2024 presidential election, new reports from the Center for Inclusive Democracy (CID) at the USC Sol Price School of Public Policy have found significant voter turnout disparities between white, non-Latino voters and voters of color in all nine battleground states. The reports highlight the persistent “voter representation gap,” where voters of color remain underrepresented at the polls, despite substantial population growth. If narrowed by November, the research concludes, this gap could significantly influence election results, particularly in swing states that had particularly close ...

The Public Health Career Explorer launches, matching health department job openings with career interests and preparation

2024-08-28
August 28, 2024-- A new, easy-to-use, evidence-based career assessment, the Public Health Career Explorer, has just launched to help job-seekers who are interested specifically in public health careers. The Public Health Career Explorer career assessment tool, three years in the making, was developed at Columbia University Mailman School of Public Health. Using the well-researched O*Net MyNextMove assessment, Columbia Mailman School’s Heather Krasna, PhD, EdM, MS, associate dean of career and professional development  painstakingly matched the Holland Codes (career interest codes) for each of the specific ...

How stigma affects Asian Americans living with hepatitis B

2024-08-28
Asian Americans comprise just 6% of the U.S. population, but they represent over 60% of Americans with hepatitis B. Hepatitis B (HBV) is a virus that infects the liver, and while some people may recover from the infection, others can go on to develop liver failure or cancer. HBV is transmitted through blood, semen or other bodily fluids, but it can also be passed from mother to child during birth, which is how the majority of Asian Americans acquire the disease. Up until 2010, laws in China allowed for discrimination against people with HBV, barring adults from employment and keeping ...

New study: drug may stop migraines before headache starts

2024-08-28
MINNEAPOLIS – When taken at the first signs of a migraine, before headache pain begins, a drug called ubrogepant may be effective in helping people with migraine go about their daily lives with little or no symptoms, according to a new study published in the August 28, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study focused on people with migraine who could tell when an attack was about to happen, due to early symptoms such as sensitivity to light and sound, fatigue, neck pain or stiffness, or dizziness.    Ubrogepant ...

Using high resolution mass spectrometry to study fuel chemistry

Using high resolution mass spectrometry to study fuel chemistry
2024-08-28
WASHINGTON  –  U.S. Naval Research Laboratory researcher Mark Romanczyk, Ph.D., developed new analytical methods to rapidly analyze fuels and complex petroleum products by using high-resolution mass spectrometry.   The approaches Romanczyk utilizes enable highly detailed qualitative analysis of complex mixtures in minutes. One recent method facilitated the investigation of chemical changes that occurred in weathered crude oil in terrestrial environments. Several of the methods were recently published in the ...

Dartmouth’s Geisel School of Medicine to launch new online Master’s Degree program in Implementation Science

2024-08-28
Preview blurb: Geisel’s new fully online 9-month MS in Implementation Science will give graduates the skills to identify and address gaps in moving evidence-based clinical practices into routine use in the real world. HANOVER, NH - “How can we more quickly and effectively move new, proven scientific evidence into routine healthcare practice? What obstacles must be overcome to embrace change and modify behavior? How can we scale a successful intervention so that more people will benefit?” These are some of the key questions future students will learn to tackle as enrollees ...

LAST 30 PRESS RELEASES:

Sensitive ceramics for soft robotics

Trends in hospitalizations and liver transplants associated with alcohol-induced liver disease

Spinal cord stimulation vs medical management for chronic back and leg pain

Engineered receptors help the immune system home in on cancer

How conflicting memories of sex and starvation compete to drive behavior

Scientists discover ‘entirely unanticipated’ role of protein netrin1 in spinal cord development

Novel SOURCE study examining development of early COPD in ages 30 to 55

NRL completes development of robotics capable of servicing satellites, enabling resilience for the U.S. space infrastructure

Clinical trial shows positive results for potential treatment to combat a challenging rare disease

New research shows relationship between heart shape and risk of cardiovascular disease

Increase in crisis coverage, but not the number of crisis news events

New study provides first evidence of African children with severe malaria experiencing partial resistance to world’s most powerful malaria drug

Texting abbreviations makes senders seem insincere, study finds

Living microbes discovered in Earth’s driest desert

Artemisinin partial resistance in Ugandan children with complicated malaria

When is a hole not a hole? Researchers investigate the mystery of 'latent pores'

ETRI, demonstration of 8-photon qubit chip for quantum computation

Remote telemedicine tool found highly accurate in diagnosing melanoma

New roles in infectious process for molecule that inhibits flu

Transforming anion exchange membranes in water electrolysis for green hydrogen production

AI method can spot potential disease faster, better than humans

A development by Graz University of Technology makes concreting more reliable, safer and more economical

Pinpointing hydrogen isotopes in titanium hydride nanofilms

Political abuse on X is a global, widespread, and cross-partisan phenomenon, suggests new study

Reintroduction of resistant frogs facilitates landscape-scale recovery in the presence of a lethal fungal disease

Scientists compile library for evaluating exoplanet water

Updated first aid guidelines enhance care for opioid overdose, bleeding, other emergencies

Revolutionizing biology education: Scientists film ‘giant’ mimivirus in action

Genetic variation enhances cancer drug sensitivity

Protective genetic mutation offers new hope for understanding autism and brain development

[Press-News.org] Leading computational scientist & oncology researcher Elana Fertig appointed new Director of the Institute for Genome Sciences
Internationally-recognized for her work in developing predictive models for drug resistance in cancer treatment